A marketing application is judged on the strength of its scientific evidence. But regulators can only evaluate that evidence when it has been translated into a complete, technically compliant, internally consistent and navigable application.
That is why a complete dossier is not necessarily a submission-ready dossier.
Regulatory operations is too often positioned at the end of the submission journey: completed documents are handed to a publishing team, assembled into an electronic common technical document (eCTD) and filed. In reality, delivering a high-quality eCTD requires sustained operational planning and execution. It should progress in parallel with regulatory strategy—not begin when the final documents are delivered.
The expertise behind a high-quality submission
Publishing a New Drug Application (NDA) or Marketing Authorization Application (MAA) is not simply a matter of operating publishing software. It is a specialized technical discipline requiring a deep understanding of eCTD architecture, validation criteria, technical specifications, metadata, document lifecycle and the navigational infrastructure reviewers rely on to move efficiently through an extensive application.
Experienced publishers also bring foresight. They recognize where submissions commonly become vulnerable, know how to resolve issues efficiently and—more importantly—can often prevent those issues from emerging in the first place.
The readiness question, therefore, is not simply whether publishing resources are available. It is whether the team has enough experienced publishers, supported by sufficient capacity to respond when document volume accelerates late in the timeline. That consideration becomes even more important for parallel NDA and MAA filings, where teams must manage distinct regional requirements, application structures and potentially different eCTD standards.
Establish the foundation before the volume arrives
Operational readiness also depends on the infrastructure surrounding the publishing process. Compliant eCTD software is essential, but it represents only one component of that foundation.
Teams need project-tracking systems that provide visibility across every module, section, source document, owner, review cycle and due date. Document management controls must preserve version integrity and ensure that the content entering the application is final and approved. Templates, styles and publishing conventions should be standardized before large volumes of documents begin moving through the process.
These capabilities cannot be implemented effectively during the final weeks before filing. Engaging regulatory operations during the readiness assessment creates time to define the submission architecture, evaluate the quality and reusability of existing content, configure tools, establish workflows and identify operational gaps before they become timeline risks.
Build quality into every stage
A clean, technically compliant eCTD is not produced through a final assembly exercise. It is built through a controlled sequence of document preparation, publishing, quality control, technical validation and dossier assembly.
Rather than waiting until every document is complete, finalized content should be transferred to regulatory operations on a rolling basis. Publishers can standardize formatting, create submission-ready PDFs, incorporate content into the eCTD structure and perform technical quality control as the application develops. In parallel, content owners can verify scientific accuracy and completeness.
Technical validation should also run continuously. Broken links, metadata errors, formatting inconsistencies and other deficiencies are far easier to address while individual sections are being built than during the final submission sprint. Once a section has completed content review, publishing review and validation, it can effectively be locked. By filing day, each module should already have undergone multiple rounds of scientific and technical review.
Turn the timeline into an integrated operating plan
This rolling approach depends on a detailed, cross-functional project plan. Regulatory strategy, CMC, nonclinical, clinical, biostatistics, medical writing and publishing should work against a shared timeline that captures dependencies, ownership, review cycles, milestones and finalization dates.
Dashboards can provide real-time visibility into overall progress, upcoming deliverables and items at risk. This allows teams to intervene before a delayed document or unresolved decision affects downstream publishing activities—and ultimately the filing date.
The objective is not simply to submit on time. It is to deliver a technically sound application that allows agency reviewers to focus on the science rather than the mechanics of the dossier.
When regulatory operations is engaged early and the eCTD is built progressively, filing day becomes the culmination of a disciplined, well-governed process—one that positions the application for efficient agency review.
